retatrutide clinical trial results weight loss 2024 2025 press release Summary of the highest percent change in completed phase 2 and Eli Lilly infiltrates anti-obesity market

Retatrutide could potentially be the next big thing in weight loss therapy

Recently, in a 6-week randomized controlled trial, we showed that the glucagon-like peptide 1 receptor agonist (GLP-1RA) liraglutide is superior to bile acid sequestration (considered standard-of-care) using colesevelam in reducing BAD symptoms

Scientific Reference 1: Holst, Physiological Reviews (2007) But they do not: restore beneficial bacteria increase SCFA production repair inflammation-driven mucosal thinning improve circadian hormone timing rebalance gutbrain appetite signalling These areas determine whether results last

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

The week-to-week consistency of your weekly injection day matters more than the hour-to-hour precision of your injection time

Since semaglutide GLP-1 works by slowing down digestion and assisting in the regulation of insulin, its normal to lose weight gradually rather than all at once during treatment